MiR-34b is associated with clinical outcome in triple-negative breast cancer patients

Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer

(2011) D. Chu et al.   ANNALS OF ONCOLOGY

The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment

(2011) Monica Fornier et al.   Breast Journal

MiR-34, SIRT1, and p53: The feedback loop

(2011) Munekazu Yamakuchi et al.   CELL CYCLE

MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer

(2011) Jelena Radojicic et al.   CELL CYCLE

Molecular heterogeneity of triple-negative breast cancer and its clinical implications

(2011) Sheeba Irshad et al.   CURRENT OPINION IN ONCOLOGY

Down-regulation ofBRCA1expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers

(2011) Amandine I. Garcia et al.   EMBO Molecular Medicine

Clinical Implication of p53 Overexpression in Breast Cancer Patients Younger than 50 Years with a Triple-negative Subtype Who Undergo a Modified Radical Mastectomy

(2011) D.-S. Lee et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Breast cancer — one term, many entities?

(2011) Nicholas R. Bertos et al.   JOURNAL OF CLINICAL INVESTIGATION

MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer

(2011) Hanna Peurala et al.   PLoS One

Frequent Downregulation of miR-34 Family in Human Ovarian Cancers

(2010) D. C. Corney et al.   CLINICAL CANCER RESEARCH

Breast Cancer Subtypes and the Risk of Local and Regional Relapse

(2010) K. David Voduc et al.   JOURNAL OF CLINICAL ONCOLOGY

Triple-negative breast cancer--current status and future directions

(2009) O. Gluz et al.   ANNALS OF ONCOLOGY

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC

(2009) N R Christoffersen et al.   CELL DEATH AND DIFFERENTIATION

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

(2009) Monika Jung et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Identification of a MicroRNA Panel for Clear-cell Kidney Cancer

(2009) David Juan et al.   UROLOGY